アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/15 | 1,986.5 | 1,996 | 1,977.5 | 1,985 | +0.5 | ±0% | 2,337,300 |
2021/11/12 | 2,019.5 | 2,019.5 | 1,976.5 | 1,984.5 | -14.5 | -0.7% | 4,334,400 |
2021/11/11 | 1,981 | 2,017 | 1,975.5 | 1,999 | +27.5 | +1.4% | 3,454,600 |
2021/11/10 | 1,967.5 | 1,999 | 1,952.5 | 1,971.5 | +14 | +0.7% | 3,245,300 |
2021/11/09 | 1,981.5 | 2,000 | 1,952.5 | 1,957.5 | -27 | -1.4% | 4,216,700 |
2021/11/08 | 1,986.5 | 1,998 | 1,980 | 1,984.5 | -8 | -0.4% | 3,118,600 |
2021/11/05 | 1,986.5 | 1,992.5 | 1,962 | 1,992.5 | +7 | +0.4% | 3,785,400 |
2021/11/04 | 1,949 | 1,986.5 | 1,934 | 1,985.5 | +61 | +3.2% | 5,132,400 |
2021/11/02 | 1,954 | 1,958.5 | 1,919.5 | 1,924.5 | -39 | -2% | 3,470,200 |
2021/11/01 | 1,969.5 | 1,969.5 | 1,905 | 1,963.5 | +46.5 | +2.4% | 4,518,800 |
2021/10/29 | 1,920 | 1,939 | 1,902.5 | 1,917 | -30 | -1.5% | 5,194,300 |
2021/10/28 | 1,950 | 1,967 | 1,940.5 | 1,947 | -20.5 | -1% | 3,052,000 |
2021/10/27 | 1,967 | 1,972 | 1,959 | 1,967.5 | ±0 | ±0% | 2,828,700 |
2021/10/26 | 1,952.5 | 1,978.5 | 1,943 | 1,967.5 | +37 | +1.9% | 3,025,000 |
2021/10/25 | 1,950 | 1,954 | 1,929 | 1,930.5 | -27 | -1.4% | 2,593,100 |
2021/10/22 | 1,942.5 | 1,968.5 | 1,936 | 1,957.5 | +6.5 | +0.3% | 2,690,800 |
2021/10/21 | 1,965 | 1,978.5 | 1,951 | 1,951 | +0.5 | ±0% | 3,556,100 |
2021/10/20 | 1,955 | 1,963 | 1,937 | 1,950.5 | +10.5 | +0.5% | 2,148,300 |
2021/10/19 | 1,976.5 | 1,976.5 | 1,940 | 1,940 | -40 | -2% | 3,017,800 |
2021/10/18 | 1,995 | 1,996 | 1,964 | 1,980 | -22 | -1.1% | 3,012,600 |
2021/10/15 | 1,976.5 | 2,004.5 | 1,973 | 2,002 | +41.5 | +2.1% | 5,316,900 |
2021/10/14 | 1,941 | 1,965 | 1,933.5 | 1,960.5 | +23.5 | +1.2% | 3,312,800 |
2021/10/13 | 1,947.5 | 1,958 | 1,934.5 | 1,937 | -16.5 | -0.8% | 3,605,000 |
2021/10/12 | 1,952 | 1,960 | 1,933.5 | 1,953.5 | -4 | -0.2% | 2,158,100 |
2021/10/11 | 1,953 | 1,978 | 1,943.5 | 1,957.5 | +14.5 | +0.7% | 3,866,200 |
2021/10/08 | 1,960 | 1,966.5 | 1,927 | 1,943 | +11.5 | +0.6% | 5,362,100 |
2021/10/07 | 1,884.5 | 1,937.5 | 1,874 | 1,931.5 | +81.5 | +4.4% | 6,477,300 |
2021/10/06 | 1,842.5 | 1,865.5 | 1,819 | 1,850 | +23 | +1.3% | 4,814,900 |
2021/10/05 | 1,835 | 1,859.5 | 1,801 | 1,827 | -35.5 | -1.9% | 4,029,100 |
2021/10/04 | 1,844.5 | 1,864 | 1,835 | 1,862.5 | +31.5 | +1.7% | 4,126,700 |
2021/10/01 | 1,838 | 1,851 | 1,816 | 1,831 | -11.5 | -0.6% | 4,066,300 |
2021/09/30 | 1,846.5 | 1,863 | 1,832.5 | 1,842.5 | +0.5 | ±0% | 6,430,700 |
2021/09/29 | 1,849 | 1,862 | 1,825.5 | 1,842 | -32.5 | -1.7% | 5,074,800 |
2021/09/28 | 1,873 | 1,881.5 | 1,850.5 | 1,874.5 | -0.5 | ±0% | 4,961,900 |
2021/09/27 | 1,904.5 | 1,912 | 1,875 | 1,875 | -27.5 | -1.4% | 4,699,800 |
2021/09/24 | 1,885 | 1,909 | 1,875.5 | 1,902.5 | +39 | +2.1% | 5,717,400 |
2021/09/22 | 1,871.5 | 1,878 | 1,854.5 | 1,863.5 | -12.5 | -0.7% | 3,637,500 |
2021/09/21 | 1,889.5 | 1,902.5 | 1,874 | 1,876 | -13 | -0.7% | 4,191,800 |
2021/09/17 | 1,892 | 1,897 | 1,875.5 | 1,889 | +6.5 | +0.3% | 6,571,200 |
2021/09/16 | 1,867.5 | 1,885 | 1,859 | 1,882.5 | +22.5 | +1.2% | 4,494,800 |
2021/09/15 | 1,876 | 1,892 | 1,858.5 | 1,860 | -44.5 | -2.3% | 5,458,800 |
2021/09/14 | 1,912 | 1,918 | 1,896 | 1,904.5 | -0.5 | ±0% | 4,386,900 |
2021/09/13 | 1,910 | 1,911 | 1,889.5 | 1,905 | +3 | +0.2% | 3,908,500 |
2021/09/10 | 1,929.5 | 1,929.5 | 1,893.5 | 1,902 | -9 | -0.5% | 7,969,900 |
2021/09/09 | 1,913.5 | 1,922 | 1,905.5 | 1,911 | -11 | -0.6% | 3,948,500 |
2021/09/08 | 1,899.5 | 1,934.5 | 1,896 | 1,922 | +1 | +0.1% | 5,079,300 |
2021/09/07 | 1,916 | 1,939 | 1,911.5 | 1,921 | +14.5 | +0.8% | 3,926,500 |
2021/09/06 | 1,895 | 1,919.5 | 1,892 | 1,906.5 | +12 | +0.6% | 4,186,900 |
2021/09/03 | 1,858.5 | 1,907 | 1,854.5 | 1,894.5 | +45.5 | +2.5% | 4,483,300 |
2021/09/02 | 1,866.5 | 1,900 | 1,838.5 | 1,849 | -55 | -2.9% | 6,315,100 |
851~
900
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム